InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Yarema Kristin, Directeur Commercial. Insider active across 4 companies, notably Atara Biotherapeutics, Inc.. Aggregated, 10 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €33k. History available since 18 May 2021. The latest transaction was filed on 14 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Yarema Kristin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
254,800 股0Common StockSEC:0001803794-26-000003:0
38,376 股0Common StockSEC:0001803794-26-000002:0
115,129 股0Common StockSEC:0001803794-26-000002:1
85,400 股0Common StockSEC:0001803794-26-000001:0
615,836 股Common StockSEC:0001415889-25-001080:0
250,000 股0Common StockSEC:0000950170-24-001835:0
356,836 股0Common StockSEC:0001209191-23-024103:0
45,533 股0Common StockSEC:0001140361-22-007766:0
2,021 股@ US$14.5072.7% 占其流量Common StockSEC:0001567619-21-012110:0
标准退出：2021年9月9日 (T+90)
761 股@ US$14.5527.3% 占其流量Common StockSEC:0001209191-21-034422:0
10 条申报中的 10 条
About Yarema Kristin
Yarema Kristin is Directeur Commercial. There are 9 filings in total, and, across the sampled recent filings, the buy and sell amounts are EUR 24074 and EUR 9058, with transactions dated from 2021-05-20 to 2026-07-28. The recent filings also mention ImageneBio, Inc., Poseida Therapeutics, Inc., and Atara Biotherapeutics, Inc.
